Cardiovascular complications in children with HIV infection (Q37885231)

24 August 2017

1 reference

title

Cardiovascular complications in children with HIV infection (English)

1 reference

24 August 2017

Amy Sims

1

1 reference

PubMed ID

21643782

24 August 2017

Colleen Hadigan

series ordinal

2

1 reference

PubMed ID

21643782

24 August 2017

language of work or name

1 reference

1 September 2011

1 reference

24 August 2017

Current HIV/AIDS reports

1 reference

24 August 2017

8

1 reference

24 August 2017

209-214

1 reference

24 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0081-9

24 August 2017

0 references

cites work

Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared with healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Increased carotid intima media thickness and cardiac biomarkers in HIV infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Impact of HIV infection on diastolic function and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Managing abnormal blood lipids: a collaborative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0081-9

Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy

21 January 2018

1 reference

12 December 2020

Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood

1 reference

12 December 2020

Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.

1 reference

12 December 2020

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine

1 reference

12 December 2020

LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.

1 reference

12 December 2020

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth

1 reference

12 December 2020

High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.

1 reference

12 December 2020

Youth risk behavior surveillance - United States, 2009.

1 reference

12 December 2020

Cardiac morbidity and related mortality in children with HIV infection

1 reference

12 December 2020

Cardiovascular manifestations of human immunodeficiency virus infection in infants and children

1 reference

12 December 2020

Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

1 reference

12 December 2020

Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study

1 reference

12 December 2020

10.1007/S11904-011-0081-9

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21643782